Pimecrolimus

Product manufactured by Remedyrepack Inc.

Application Nr Approved Date Route Status External Links
ANDA209345 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Pimecrolimus Cream, 1% Is Indicated As Second-Line Therapy For The Short-Term And Non-Continuous Chronic Treatment Of Mild To Moderate Atopic Dermatitis In Non-Immunocompromised Adults And Children 2 Years Of Age And Older, Who Have Failed To Respond Adequately To Other Topical Prescription Treatments, Or When Those Treatments Are Not Advisable. Pimecrolimus C Ream, 1% Is Not Indicated For Use In Children Less Than 2 Years Of Age [see Warnings And Precautions (5.1) , Use In Specific Populations (8.4) ]. Pimecrolimus Cream, 1% Is A Calcineurin Inhibitor Immunosuppressant Indicated As S E C O N D -L I N E Th E R A P Y For The Short-Term And Non-Continuous Chronic Treatment Of Mild To Moderate Atopic Dermatitis In Non-Immunocompromised Adults And Children 2 Years Of Age And Older, Who Have Failed To Respond Adequately To Other Topical Prescription Treatments, Or When Those Treatments Are Not Advisable. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Pimecrolimus PIMECROLIMUS ZINC169356261

Comments